© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 VAC AD26 .5ML | Medium Descr | IMM ADMN SARSCOV2 AD26 5X1010VP/0.5 ML 1 DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; single dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-06-01 | Note | This code, 0031A, is no longer authorized for use in the United States. |
| 2023-06-01 | Note | These codes (included in the guidelines) are no longer authorized for use in the United States: 0034A & 91303. |
| 2023-01-01 | Changed | First appearance of change(s) in codebook. |
| 2022-08-31 | Note | Changes made to vaccine dosing information, & patient age (18 yrs and older). |
| 2022-01-01 | Added | First appearance of code in codebook. |
| 2022-01-01 | Note | Grammar correction |
| 2022-01-01 | Changed | Code description changed. |
| 2021-10-20 | Changed | Code description change released to AMA website 2021-10-27. Effective retroactively to 2021-10-20. |
| 2021-10-20 | Note | AMA guideline changed to include 0034A 2022-10-27. Effectively retroactively to 2021-10-20 |
| 2021-02-27 | Note | FDA approval received. |
| 2021-02-27 | Note | AMA Guideline changed. 91303 received FDA approval |
| 2021-02-27 | Added | Code added. |
| 2021-01-19 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |
| 2021-01-19 | Note | AMA guideline added to include 91303; Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the FDA. |
Get instant expert-level medical coding assistance.